souvik101990
Patient advocate: A new pancreatic cancer treatment has proven to decrease mortality by 10% over the treatments currently available under your company's insurance plans. Allowing doctors to prescribe the new treatment could save many lives.
Insurer: You fail to recognize that the new treatment is more than twice as expensive as the others. Including the new treatment in our plans would more than double our costs - and therefore dramatically increase premiums - while providing only marginally better care.
Which of the following is an assumption required by the insurer's argument?
(A) Insurance companies should not value the saving of lives more than they value corporate profits.
(B) New treatments should only be included in insurance plans if they increase positive patient outcomes at a higher percentage than they increase costs.
(C) There is no affordable test to determine which patients' lives would be more likely saved by the new treatment than by the old treatment.
(D) No other insurance companies offer the new cancer treatment in their insurance plans.
(E) The pancreatic cancer treatments currently offered by the insurer's plans will not become more effective over time.
I will go with C here is why:-
Patient's Advocate:-
Premise: A new treatment has proven to decrease mortality rate by 10 % and therefore Conclusion 1: Allowing doctor to prescribe new prescription can save many life.
Insurance Company:-
Premise: The new treatment is 2 times more expensive and including new treatment in our plan will increase the premium while only marginally provide better care.
Conclusion 2:
dramatic increase in premium (200%) is not justified for marginal improvement (10% improvement) in healthcare. therefore it should not be included in the plan.we have to find out the option which is required assumption for conclusion 2
No let us look on the answer choices one by one
(A) Insurance companies should not value the saving of lives more than they value corporate profits.-- lets negate this--- insurance company should value the saving lives more than they value corporate
profit.-- Irrevlevant the conclusion does not talk about profit it is talking about increased
premium or cost.(B) New treatments should only be included in insurance plans if they increase positive patient outcomes at a higher percentage than they increase costs.--
tempting one:- but this is not neccessary, please look on the word ONLY. The insurance company may include the new treatment even if it sees 70 to 80 % improvement with 200% increase in cost we never know(C) There is no affordable test to determine which patients' lives would be more likely saved by the new treatment than by the old treatment- Correct Answer:-
Lets negate this. There are some affordable test to determine which patients lives would be more likely saved- this means that those who know that their life will be more likely to be saved will pay 200% to increase their chances of survival (of course by some greater margin than 10%) while others can keep on paying the lower premium, and therefore this gives a reason why insurance company should include it in its plan.
(D) No other insurance companies offer the new cancer treatment in their insurance plans.--
irrelevant(E) The pancreatic cancer treatments currently offered by the insurer's plans will not become more effective over time.---
irelevant